The families harboring the T790M or V843I mutations are predisposed to NSCLC development as these mutations contribute to tumorigenesis by promoting phosphorylation of EGFR and its downstream signaling proteins. This evidence concerns the gene EGFR and non-small cell lung carcinoma.